Founding Story Purple 1920x1080 Aspect Ratio 1200 384

Founding Story

The beginnings of Vor Bio’s approach

Our founding science was developed by the research team led by Dr. Siddhartha Mukherjee, MD, DPhil.

Dr. Siddhartha Mukherjee and his team published the proof-of-concept study for our lead program in the Proceedings of the National Academy of Sciences.

A word from our founder

Today, working seamlessly across departments and encouraging the free flow of ideas, leading HSC biologists, genome engineers, cancer immunologists, manufacturing experts, clinicians, and others make up a passionate team striving to collaboratively develop a novel approach to cancer treatment, one of medicine’s greatest challenges.

The Latest from the Vor Bio Blog

10

From Concept to Clinical Trial Results: A Conversation with Glen Raffel, MD, PhD, VP of Clinical Research & Development

by Erin Phelps
Clinical Trials | Vor’s first-in-human clinical trial of VBP101
As we continue to share results from our first clinical trial, VBP101, we checked in with our Vice President of Clinical Research & Development, Glen Raffel, MD, PhD, to find out what it’s like seeing this concept progress from an idea to a clinical trial where we are now seeing results in patients who have received this drug candidate.
Read More
Hannah Blog

Reflections of a Vor Bio Scientist

by Erin Phelps
Hannah Mager, a beloved Associate Scientist II on our Discovery and Molecular Engineering team, recently concluded her time at Vor Bio to pursue her PhD, and we couldn’t be more proud of her! Prior to her departure, Hannah shared key learnings from her time here and shared advice for other young scientists looking to take the next step in their careers.
Read More
Load More
Our Approach

Vor Bio’s unique approach aims to shield the healthy cells, attack the cancer.

Our Approach